Neuronetics Inc (STIM) Stock Analysis

Neuronetics Inc (STIM) is a publicly traded company in the HEALTHCARE sector. It trades at $1.56, carries a market capitalization of $116.21M. This page summarizes the public market data, fundamentals, and frequently asked questions for STIM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $1.56
• Market Cap: $116.21M
• EPS: $-0.54
• 52-Week High: $4.85
• 52-Week Low: $0.80

Market Sentiment

Neuronetics Inc currently has a Bullish sentiment score of 0.22.

About Neuronetics Inc

Neuronetics, Inc. (STIM) is a commercial-stage medical technology company specializing in innovating and marketing non-invasive therapeutic solutions for psychiatric disorders, with a strong emphasis on major depressive disorder and obsessive-compulsive disorder. Headquartered in Malvern, Pennsylvania, Neuronetics leverages its proprietary neurostimulation technology to offer effective treatment options, targeting the growing demand for advanced mental health therapies. With a commitment to i...

GNG Research Analysis

GNG Research scores Neuronetics Inc (STIM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for STIM.

Frequently Asked Questions

Does STIM pay dividends?

Neuronetics Inc (STIM) does not currently pay a regular dividend.

What is STIM's market cap?

Neuronetics Inc (STIM) has a market capitalization of $116.21M with a current stock price of $1.56.